tiprankstipranks
Advertisement
Advertisement
TuHURA Biosciences says FDA grants Orphan Drug Designation to IFx-2.0
PremiumThe FlyTuHURA Biosciences says FDA grants Orphan Drug Designation to IFx-2.0
2M ago
TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice
Premium
Company Announcements
TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice
2M ago
TuHURA Biosciences price target lowered to $10 from $12 at H.C. Wainwright
Premium
The Fly
TuHURA Biosciences price target lowered to $10 from $12 at H.C. Wainwright
3M ago
TuHURA Biosciences presents research on potential role of DOR at ASH
PremiumThe FlyTuHURA Biosciences presents research on potential role of DOR at ASH
4M ago
TuHURA Biosciences Amends Loan Agreement, Secures Full $3M
Premium
Company Announcements
TuHURA Biosciences Amends Loan Agreement, Secures Full $3M
4M ago
TuHURA Biosciences’ Shelf Registration Statement Effective
Premium
Company Announcements
TuHURA Biosciences’ Shelf Registration Statement Effective
4M ago
TuHURA Biosciences files $250M mixed securities shelf
PremiumThe FlyTuHURA Biosciences files $250M mixed securities shelf
5M ago
TuHURA Biosciences Plans Phase 2 Trial for TBS-2025
Premium
Company Announcements
TuHURA Biosciences Plans Phase 2 Trial for TBS-2025
5M ago
TuHURA Biosciences Secures $3M Bridge Loan Agreement
Premium
Company Announcements
TuHURA Biosciences Secures $3M Bridge Loan Agreement
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100